Efficacy of Vorinostat to Induce Fetal Hemoglobin in Sickle Cell Disease
Clinical trial NCT01000155 · TERMINATED
Trial details
- NCT number
- NCT01000155
- Sponsor
- Dana-Farber Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-01
- Primary completion
- 2014-10-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.